SEC Form EFFECT filed by NewGenIvf Group Limited
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | June 3, 2025 4:30 P.M. |
Form: | F-1 | ||||||
|
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | June 3, 2025 4:30 P.M. |
Form: | F-1 | ||||||
|
Save time and jump to the most important pieces.
3 - NewGenIvf Group Ltd (0001981662) (Issuer)
BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced plans to invest US$30 million in staking the digital asset Solana, marking a substantial expansion of the company's digital asset investment strategy. The investment will be funded through existing credit facilities of US$26 million and US$100 million with ATW and White Lion, respectively. Solana is recognized as one of the leading blockchain platforms, known for its high-speed transaction processing capabilities and growing ecosystem of dece
BANGKOK, May 27, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that its wholly owned subsidiary, First Fertility PGS Center Limited ("First Fertility"), has launched a strategic expansion initiative targeting the Indian medical tourism market for fertility treatments. This initiative positions NewGen to capitalize on Thailand's rapidly growing fertility tourism sector, which has emerged as a preferred destination for international patients seeking advanced reproductive care. According to ResearchAndMarkets,
BANGKOK, May 07, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on the integration of its recently acquired MicroSort® technology. The strategic integration of this technology – which the company has rebranded to NewGenSort – marks a significant advancement in the company's mission to provide comprehensive, cutting-edge reproductive solutions to couples and individuals throughout Asia. NewGenSort enables the separation of X and Y chromosome-bearing sperm cells prior to fertilization procedures. I
6-K - NewGenIvf Group Ltd (0001981662) (Filer)
EFFECT - NewGenIvf Group Ltd (0001981662) (Filer)
424B3 - NewGenIvf Group Ltd (0001981662) (Filer)
Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to specific conditions. Additionally, the Company announced the appointment of Mr. Thorain Ko as Business Development Director to drive its expansion initiatives. Nasdaq Listing UpdateThe Pane
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)